We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cobra Biologics and Algeta Sign Agreement to Manufacture Monoclonal Antibody

News   Jan 15, 2013

 
Cobra Biologics and Algeta Sign Agreement to Manufacture Monoclonal Antibody
 
 
 

RELATED ARTICLES

Ebola Vaccine Could Stretch Farther

News

A new study has identified that a single dose of a highly diluted Ebola vaccine still fully protected against disease in a monkey model.

READ MORE

Creatine Fuels T Cells’ Fight Against Cancer

News

Creatine serves as a molecular battery for immune cells by storing and distributing energy to fuel their fight against cancer, according to a new study.

READ MORE

A New Way of Creating the Building Blocks of Drugs

News

A team have discovered how to synthesize the most common molecule arrangement in medicine, a scientific discovery that could change the way a number of drugs are produced.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE